Victor Forge
Acetylcholine (ACh) is a neurotransmitter that interacts with muscarinic and nicotinic receptors in the central and peripheral nervous systems. ACh is the primary excitatory neurotransmitter in visceral smooth muscles, wherein it binds to and activates two muscarinic receptors, M2 and M3, thus causing smooth muscle excitation and contraction. ACh is released by motor neurons and binds to receptors in the motor end plate. ACh-induced membrane depolarisation is the central event of excitation-contraction coupling in visceral smooth muscles.
| Characteristics | Values |
|---|---|
| Definition | Acetylcholine (ACh) is a neurotransmitter that interacts with muscarinic and nicotinic receptors in the central and peripheral nervous systems. |
| Function | ACh controls or modulates physiological processes, including the regulation of skeletal and smooth muscle contraction, heart rate, and higher brain functions like attention, learning, and memory. |
| Excitation-Contraction Coupling | ACh-induced membrane depolarization triggers excitation-contraction coupling, leading to smooth muscle contraction. |
| Muscarinic Receptors | ACh binds to and activates two muscarinic receptor subtypes, M2 and M3, causing smooth muscle excitation and contraction. |
| Action of ACh | ACh binds to receptors on the plasma membrane of the muscle fiber, allowing an action potential to reach the endoplasmic reticulum and release calcium ions. |
| Calcium Ions | Calcium ions bind to actin, causing actin filaments to shift position and revealing myosin binding sites, leading to muscle contraction. |
| Role in Locomotion | ACh receptors regulate the balance between excitation and inhibition in muscles, contributing to coordinated contraction and relaxation for locomotion. |
| Degradation | ACh is broken down by the enzyme acetylcholinesterase (AChE) to prevent extended muscle contraction. |
| Neural Stimulation | ACh is released by motor neurons, activating skeletal muscles and inducing muscle contraction. |
Explore related products
What You'll Learn
Acetylcholine (ACh) is a neurotransmitter
ACh is released by motor neurons and binds to receptors in the motor end plate, which is the area of the sarcolemma on the muscle fibre that interacts with the neuron. The motor end plate possesses junctional folds that increase the surface area for ACh to bind to receptors. The receptors are sodium channels that open in response to the ACh signal, allowing the passage of Na+ ions into the cell and initiating the action potential.
The role of ACh in muscle contraction is regulated by acetylcholinesterase (AChE), an enzyme that breaks down ACh into acetyl and choline. AChE resides in the synaptic cleft, preventing ACh from remaining bound to ACh receptors and causing unwanted extended muscle contraction. This regulation is crucial, as evidenced by the effects of the nerve gas Sarin, which inhibits AChE and leads to continuous muscle stimulation, initially resulting in intense and uncontrolled muscle activity before causing paralysis and death by asphyxiation.
In addition to its role in muscle contraction, ACh has broader physiological significance due to its ubiquitous distribution. It controls or modulates various processes, including the regulation of skeletal and smooth muscle contraction, heart rate modulation, and higher brain functions such as attention, learning, memory, arousal, and reward. Alterations in ACh signalling have been implicated in a range of disorders, including myasthenias, cardiovascular disease, gastrointestinal disorders, addiction, ADHD, and Alzheimer's disease.
Coreg's Impact: Muscle Fatigue and You
You may want to see also
Explore related products
ACh binds to receptors in the motor end plate
Acetylcholine (ACh) is a neurotransmitter that interacts with muscarinic and nicotinic receptors in the central and peripheral nervous systems. ACh is released by motor neurons and binds to receptors in the motor end plate. The motor end plate possesses junctional folds—folds in the sarcolemma that create a large surface area for the neurotransmitter to bind to receptors.
The binding of ACh to neuronal nicotinic receptors results in a conformational change and the formation of an ion pore that allows the movement of cations, specifically the influx of Ca2+ ions that stimulate the release of neurotransmitters. In the sliding filament model of muscle contraction, the thicker myosin filaments have cross-bridges that attach and detach from thinner actin filaments. The binding of myosin to actin causes the actin filaments to slide, shortening the muscle fiber.
ACh-induced membrane depolarisation is the central event of excitation-contraction coupling in visceral smooth muscles. Activated M2 and M3 muscarinic receptor subtypes act in synergy to open TRPC4 channels, initiating membrane depolarisation. Acetylcholine is the primary excitatory neurotransmitter in visceral smooth muscles, where it binds to and activates two muscarinic receptor subtypes, M2 and M3, thus causing smooth muscle excitation and contraction.
The ACh action is terminated by its degradation into choline and acetate by acetylcholinesterase (AChE) at neuromuscular and neuroeffector junctions. AChE resides in the synaptic cleft, breaking down ACh so that it does not remain bound to ACh receptors, which would cause unwanted extended muscle contraction.
Iron Pills and Leg Pain: What's the Link?
You may want to see also
Explore related products
Excitation-contraction coupling
The excitation-contraction coupling (ECC) phenomenon was defined by Alexander Sandow in 1952 as the rapid communication between electrical events occurring in the plasma membrane of skeletal muscle fibres and Ca2+ release from the SR, which leads to contraction. ECC refers to the steps in a process of muscular contraction from action potential (excitation) to the power stroke (contraction). It is the physiological mechanism by which an electric discharge in muscle tissue initiates the chemical events leading to muscle contraction.
ECC can be categorized into three phases. The first phase involves the depolarization and spread of an action potential (AP) along the sarcolemma and the propagation of the AP into the T tubules. The second phase involves the release of calcium from the sarcoplasmic reticulum, which binds to the troponin molecules on the thin filament. The binding of calcium to troponin causes troponin to undergo a configurational change, thereby removing tropomyosin from its blocking position on the actin filament.
The third phase of ECC is the cross-bridging cycle, which describes the cyclic events necessary for the generation of force or tension within the myosin heads during muscle contraction. The generation of tension within the contractile elements results from the binding of the myosin heads to actin and the subsequent release of stored energy in the myosin heads. ECC is mediated by calcium metabolism. When an action potential occurs, voltage-gated calcium channels allow calcium into the cell, activating calcium release from ryanodine receptors at the sarcoplasmic reticulum, and causing contraction.
In the detrusor smooth muscle, the ligand is ACh and the receptor is the M3 receptor. At rest, there is a very low concentration of free calcium ions (Ca2+) in the smooth muscle cell. Binding of ACh to the M3 receptor triggers a G protein–mediated process, which causes Ca2+ release from the sarcoplasmic reticulum as well as Ca2+ influx from transmembrane ion channels. The free Ca2+ binds to calmodulin, and the Ca2+-calmodulin complex then activates the enzyme myosin light chain kinase, which phosphorylates the light chain of the contractile protein, myosin. This phosphorylation causes the myosin light chain to change shape and interact with actin, causing force generation.
Muscle Injuries: A Cellulitis Risk?
You may want to see also
Explore related products
Muscarinic receptors and their subtypes
Acetylcholine is the primary excitatory neurotransmitter in visceral smooth muscles, wherein it binds to and activates two muscarinic receptor subtypes, M2 and M3, thus causing smooth muscle excitation and contraction. The activation of both the M2 receptor and the M2/M3 receptor complex elicits smooth muscle contraction at low agonist concentrations. At high agonist concentrations, the M3 receptor function becomes dominant.
The M1 receptor (Gq) is present in the cerebral cortex, hippocampus, and throughout the brain, and appears to play a role in cognitive functioning. M2 receptors (Gi) are found in the atrium of the heart and the sinoatrial node. When activated, they inhibit sympathetic influence on the heart, reducing contractility and decreasing firing from the sinoatrial node, leading to an overall reduction in heart rate. M3 receptors (Gq) are present in smooth muscle structures such as the bronchi, gastrointestinal tract, pupils, and blood vessels. They are involved in bronchial constriction, gastrointestinal and gallbladder smooth muscle contraction, pupil constriction, and vasodilation of the blood vessels.
M4 receptors (Gi) are found in the CNS. M2 and M1 receptors mediate slow EPSP at the ganglion in the postganglionic nerve, and are common in exocrine glands and in the CNS. They are also found in the detrusor muscle, where they are involved in bladder contraction.
The nicotinic receptor, which is the counterpart of the muscarinic acetylcholine receptor, subdivides into two subtypes, N1 and N2. N1 is the peripheral or muscle receptor type, found at the neuromuscular junction of skeletal muscle. N2 is the central or neuronal receptor subtype, found within the peripheral and central nervous systems.
Stair Climbing: Risks of Pulled Thigh Muscles
You may want to see also
Explore related products
ACh's role in muscle contraction
Acetylcholine (ACh) is an organic compound that acts as a neurotransmitter in the brain and body of many animal types, including humans. It is a chemical that motor neurons release to activate muscles. ACh is synthesized in certain neurons by the enzyme choline acetyltransferase, which combines choline and acetyl-CoA. It is stored at the end of nerve cells and released into the synaptic cleft when triggered.
ACh plays a role in contracting voluntary muscles, and is the primary excitatory neurotransmitter in visceral smooth muscles. Here, it binds to and activates two muscarinic receptor subtypes, M2 and M3, causing smooth muscle excitation and contraction. ACh-induced membrane depolarization is the central event of excitation-contraction coupling in visceral smooth muscles.
In the sliding filament model of muscle contraction, ACh binds to receptors on the plasma membrane of the muscle fiber, allowing an action potential to move to the endoplasmic reticulum, where calcium ions are stored. The release of calcium ions in response to the change in voltage causes them to bind to actin, resulting in the actin filaments shifting position and revealing myosin binding sites. This action requires energy, which is provided by ATP.
ACh is broken down by the enzyme acetylcholinesterase (AChE) into acetyl and choline. AChE is found in the synaptic cleft, where it breaks down ACh so that it does not remain bound to ACh receptors, preventing unwanted extended muscle contraction.
ACh has a variety of functions in the body, including regulating heart contractions, blood pressure, and decreasing heart rate. It also plays a role in memory, learning, attention, arousal, and motivation.
Fitness Trackers: Unintended Consequence of Muscle Pain?
You may want to see also
Frequently asked questions
Acetylcholine (ACh) is a neurotransmitter that interacts with muscarinic and nicotinic receptors in the central and peripheral nervous systems. ACh is released by motor neurons and binds to receptors in the motor end plate, inducing muscle contraction.
If ACh remains bound to ACh receptors, it can cause unwanted extended muscle contraction. This can be observed in the presence of nerve gas Sarin, which inhibits the removal of ACh from the synapse, resulting in continuous muscle stimulation and eventually leading to paralysis.
Alterations in cholinergic signaling can result in a wide range of disorders, including myasthenias, cardiovascular disease, gastrointestinal disorders, addiction, ADHD, and Alzheimer's disease. Understanding the role of ACh in these conditions can help develop treatments, such as using inhibitors of acetylcholinesterase for Alzheimer's disease.
